POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES Drug Patent Profile
✉ Email this page to a colleague
When do Polyethylene Glycol 3350 And Electrolytes patents expire, and when can generic versions of Polyethylene Glycol 3350 And Electrolytes launch?
Polyethylene Glycol 3350 And Electrolytes is a drug marketed by Paddock Llc and Strides Pharma and is included in two NDAs.
The generic ingredient in POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous. There are four hundred and twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
- What are the global sales for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
- What is Average Wholesale Price for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES?
Summary for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Clinical Trials: | 14 |
| DailyMed Link: | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES at DailyMed |
Recent Clinical Trials for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| General Hospital of Shenyang Military Region | NA |
| Hitit University | PHASE4 |
| Institute of Medical Sciences and SUM Hospital | PHASE4 |
See all POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES clinical trials
Pharmacology for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| Drug Class | Osmotic Laxative Potassium Salt |
| Mechanism of Action | Osmotic Activity |
| Physiological Effect | Increased Large Intestinal Motility Inhibition Large Intestine Fluid/Electrolyte Absorption Stimulation Large Intestine Fluid/Electrolyte Secretion |
US Patents and Regulatory Information for POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Paddock Llc | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 090712-001 | Feb 25, 2010 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Strides Pharma | POLYETHYLENE GLYCOL 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 204558-001 | Dec 21, 2018 | AA | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
